Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care.
about
Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Bruton's tyrosine kinase inhib ...... ing clinical standard-of-care.
@en
type
label
Bruton's tyrosine kinase inhib ...... ing clinical standard-of-care.
@en
prefLabel
Bruton's tyrosine kinase inhib ...... ing clinical standard-of-care.
@en
P2093
P2860
P1433
P1476
Bruton's tyrosine kinase inhib ...... ting clinical standard-of-care
@en
P2093
Aberra Fura
Claudine Pulicicchio
Dana Banas
Daniel W Kukral
Elizabeth M Heimrich
Jignesh Nagar
Joseph A Tino
Kathleen M Gillooly
Kim W McIntyre
Lihong Cheng
P2860
P304
P356
10.1371/JOURNAL.PONE.0181782
P407
P577
2017-07-24T00:00:00Z